Since, in this study, DMF did not alter BP, plasma markers of kidney damage, or Nos3 gene expression and did not reduce NOS activities in the LHV under control conditions, LHV hypertrophy observed in DMF-treated rats must be attributed to other mechanisms. This evidence concerns the gene NOS2 and Nephropathy.